The US Food and Drug Administration has awarded $2.9 million to support six research projects aimed at helping with the diagnosis, treatment and prevention of tuberculosis. The awards were issued under the agency’s Critical Path Initiative. ---Subscribe to MedNous to access this article--- Regulation & Policy Research & University News
